Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
190 Leser
Artikel bewerten:
(0)

Endometriosis Foundation of America Hosts the 5th Annual Scientific Medical Conference on March 7 To Kick-Off Endometriosis Awareness Month

Finanznachrichten News

NEW YORK, Feb. 26, 2014 /PRNewswire/ -- The Endometriosis Foundation of America (EFA), founded by Tamer Seckin, MD, and Padma Lakshmi, continues to demonstrate its commitment to promoting better health and quality of life for women with endometriosis by hosting its 5th Annual Medical Conference addressing Politics, Ethics and Controversies in Endometriosis and Women's Health - a two-day meeting open to both medical professionals and women with endometriosis.

EFA, the Nation's leading non-profit organization dedicated to increasing the recognition of endometriosis, will host the New York City conference at the Metropolitan Club where world renowned experts, master surgeons, and scientists will present the latest advances in the diagnosis and treatment of the disease.

"The conference highlights the politics of women's health rights, and treatment of women from medical, legal, and ethical perspectives," said Dr. Tamer Seckin, scientific chair of the conference and co-founder of the EFA with Padma Lakshmi. "My vision has always been to start a dialogue about the state of American women's health, particularly, for women with endometriosis. This is a misunderstood, often times misdiagnosed, disease, which, in this country, is not talked about enough. There is a lot of bias, prejudice, and discrimination against women with endometriosis in school and in the workplace and from the healthcare system in general. EFA's mission is to change this!"

Dr. Seckin has established the Harry Reich Award in honor of Dr. Reich's pioneering work in laparoscopic surgery and his lifetime commitment to perfecting minimally invasive procedures in women's healthcare. Professor Liselotte Mettler from the University of Kiel and Professor Linda C. Giudice from the University of California, San Francisco, will be the first two recipients of this award. "These two extraordinary women - a surgeon and a scientist whose own seminal work and careers mirror the contributions of Dr. Reich - have improved the lives of thousands of women around the world," said Dr. Seckin.

A groundbreaking provocative discussion on the politics of endometriosis will feature three political advocates: Byllye Avery, founder of the Black Women's Health Imperative and the Avery Institute for Social Change; Lone Hummelshoej, Secretary General of the World Endometriosis Society (WES); and Judith Waxman, Vice President of Health and Reproductive Rights at the National Women's Law Center.

Other topics will include the controversies in cancer and endometriosis, ethical fertility treatment, managing chronic pain, immunity, stem cells, and the role of robotic surgery. Prominent speakers include Frank Chervenak, MD, world-renowned OBGYN ethicist and the chair of the OBGYN department at Weill Medical College of Cornell University, and Robert Kurman, MD, Professor of Gynecology and Obstetrics, Oncology and Pathology and Director of Gynecologic Pathology at the Johns Hopkins University School of Medicine.

"EFA is proud to host this annual conference and to be affiliated with such talented doctors and experts in the medical field.So many women aren't getting treatment because they aren't properly diagnosed.Education and awareness is the key to a better understanding of endometriosis. Asking questions when visiting your doctors is the beginning,"says EFA co-founder and endometriosis sufferer, Padma Lakshmi, author and host of Top Chef.

Faculty for the conference are affiliated with North Shore LIJ Health System/Feinstein Institute for Medical Research; North Shore LIJ Health System/Lenox Hill Hospital; Brigham and Women's Hospital - Boston Hospital & Medical Center; Memorial Sloan Kettering; John Hopkins University; NYU Langone Medical Center; New York Presbyterian Hospital, Weill Medical College of Cornell University; University of British Columbia; Michigan State University; University Hospitals Schleswig-Holstein, Kiel, Germany; University of California, San Francisco; and Columbia Presbyterian Medical Center. For more information or to register for the conference visit www.endofound.org, call 516-361-2181, or email mdconference2014@endofound.org.

Dr. Tamer Seckin is a leading authority on the topic of endometriosis and various related reproductive conditions and treatments, including hysterectomy. He is one of a select few accredited U.S. surgeons to specialize in innovative minimally invasive techniques such as laparoscopic surgery. His expertise in this field has allowed him to found the Endometriosis Foundation of America (EFA) and Hysterectomy.com, a comprehensive resource women can use to better understand hysterectomy surgery and available alternatives. You can learn more about Dr. Seckin on http://www.hysterectomy.com.

SOURCE Dr. Tamer Seckin

© 2014 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.